These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4219271)

  • 21. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti tubercular activity of garlic oil.
    Jain RC
    Indian J Pathol Microbiol; 1998 Jan; 41(1):131. PubMed ID: 9581089
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of various combinations of antitubercular agents on the course of experimental tuberculous infections and development of drug resistance].
    Durisić M; Davidović C; Jovanović M; Marković Lj
    Glas Srp Akad Nauka Med; 1975; (26):17-23. PubMed ID: 816709
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary resistance of Mycobacterium tuberculosis].
    Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
    Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
    [No Abstract]   [Full Text] [Related]  

  • 25. [Principles of the antitubercular therapy].
    Bojalil LF
    Gac Med Mex; 1975 Jul; 110(1):63-6. PubMed ID: 807497
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
    Pfyffer GE
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the biological properties of Mycobacterium tuberculosis as affected by x-ray radiation].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1986; (9):47-50. PubMed ID: 3097634
    [No Abstract]   [Full Text] [Related]  

  • 30. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control.
    Iseman MD; Sbarbaro JA
    Curr Clin Top Infect Dis; 1992; 12():188-207. PubMed ID: 1642799
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary resistance of Mycobacterium tuberculosis in Brazil].
    de Lima Filho MT; de Oliveira AG; Nishi I; Saraiva LG; de Melo FA
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):182-4. PubMed ID: 6781015
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the role of the macroorganism in the appearance of bacillary resistance].
    Nitti V
    Ftiziologia; 1971; 20(3):245-8. PubMed ID: 5005958
    [No Abstract]   [Full Text] [Related]  

  • 38. [Primary resistance].
    Giunio N
    Plucne Bolesti; 1985; 37(1-2):50-5. PubMed ID: 3934691
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acquired resistance of M tuberculosis to the antitubercular drugs in Chile from 1988 to 1991].
    Guzmán AM; García P; Valenzuela MT; Piffardi S; Lepe R; Velasco M; Vergara MI
    Rev Med Chil; 1993 Nov; 121(11):1269-73. PubMed ID: 8191133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.